AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 272: R1826-R1833, 1997;
0363-6119/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trigazis, L.
Right arrow Articles by Anderson, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trigazis, L.
Right arrow Articles by Anderson, G. H.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 272, Issue 6 1826-R1833, Copyright © 1997 by American Physiological Society


ARTICLES

Effect of a cholecystokinin-A receptor blocker on protein-induced food intake suppression in rats

L. Trigazis, A. Orttmann and G. H. Anderson
Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Ontario, Canada.

To test the hypothesis that only dietary protein (Pro; chicken egg albumin) and not amino acids (AA), carbohydrates (CHO; cornstarch), or fats (Fat; corn oil) produces a satiating effect via cholecystokinin (CCK) receptors, devazepide was coadministered with each macronutrient. Given alone (in 4 ml ig), Pro (0.75, 1.0, and 1.5 g), AA (1.0 g), CHO (1.4 g), and Fat (2.4 g) suppressed (P < 0.05) food intake in the first hour by 0.5, 0.8, and 1.1 g; 1.9 g; and 1.0 g, respectively, and in the first 2 h of feeding by 0.8, 1.2, and 1.3 g; 1.7 g; 0.7 g; and 1.5 g, respectively. When coadministered with devazepide (0.5 mg/kg body wt ig), the suppression of food intake caused by Pro, AA, CHO, and Fat treatments was modulated in the first hour by 60, 50, and 55%; 16%, 11%; and 10%, respectively, and during 0-2 h by 63, 92, and 54%; 29%; 0%; and -20%, respectively. Devazepide (0.5 mg/kg) given intraperitoneally also modulated Pro intake suppression during the first hour by 33% and during 0-2 h by 79%. Devazepide appears to interact with mechanisms of Pro-induced food intake suppression, but not AA-, Fat-, or CHO-induced food intake suppression. These studies provide evidence that CCK receptors play a role in Pro (albumin)- but not AA-, CHO (corn starch)-, or Fat (corn oil)-induced food intake suppression in rats.


This article has been cited by other articles:


Home page
J. Nutr.Home page
A. Aziz and G. H. Anderson
Exendin-4, a GLP-1 Receptor Agonist, Interacts with Proteins and Their Products of Digestion to Suppress Food Intake in Rats
J. Nutr., July 1, 2003; 133(7): 2326 - 2330.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Nishi, H. Hara, and F. Tomita
Soybean {beta}-Conglycinin Peptone Suppresses Food Intake and Gastric Emptying by Increasing Plasma Cholecystokinin Levels in Rats
J. Nutr., February 1, 2003; 133(2): 352 - 357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. D. Reidelberger, D. Heimann, L. Kelsey, and M. Hulce
Effects of peripheral CCK receptor blockade on feeding responses to duodenal nutrient infusions in rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R389 - R398.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Pupovac and G. H. Anderson
Dietary Peptides Induce Satiety via Cholecystokinin-A and Peripheral Opioid Receptors in Rats
J. Nutr., September 1, 2002; 132(9): 2775 - 2780.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Aziz and G. H. Anderson
Exendin-4, a GLP-1 Receptor Agonist, Modulates the Effect of Macronutrients on Food Intake by Rats
J. Nutr., May 1, 2002; 132(5): 990 - 995.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. A. Froetschel, M. J. Azain, G. L. Edwards, C. R. Barb, and H. E. Amos
Opioid and Cholecystokinin Antagonists Alleviate Gastric Inhibition of Food Intake by Premeal Loads of Casein in Meal-Fed Rats
J. Nutr., December 1, 2001; 131(12): 3270 - 3276.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. T. Peters, Y.-H. Choi, P. L. Brubaker, and G. H. Anderson
A Glucagon-Like Peptide-1 Receptor Agonist and an Antagonist Modify Macronutrient Selection by Rats
J. Nutr., August 1, 2001; 131(8): 2164 - 2170.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y.-H. Choi and G. H. Anderson
An Interaction between Hypothalamic Glucagon-Like Peptide-1 and Macronutrient Composition Determines Food Intake in Rats
J. Nutr., June 1, 2001; 131(6): 1819 - 1825.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Woltman and R. Reidelberger
Role of cholecystokinin in the anorexia produced by duodenal delivery of peptone in rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1701 - R1709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Trigazis, F. J. Vaccarino, C. E. Greenwood, and G. H. Anderson
CCK-A receptor antagonists have selective effects on nutrient-induced food intake suppression in rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R323 - R330.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online